Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery
Preserving Brain Health After Surgery: Does Light General Anesthesia Reduce Postoperative Delirium and Cognitive Decline Compared With Deep General Anesthesia in Older Adults?
Auckland City Hospital
2,766 participants
May 20, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial (Balanced-2 study) is to compare light to deep general anesthesia using widely available brain monitors, to see if 'light' anesthesia could reduce rates of delirium, cognitive decline, and disability in older adults undergoing major surgery. Delirium is the most common serious surgical complication, occurring in an estimated one in four older adults undergoing major surgery. Delirium causes significant distress to patients and family, and is associated with prolonged hospital stay, physical disability, progression to dementia-like illnesses, and discharge to long-term care. Between 10 - 30% of adults aged 70 years and above have surgery every year, and preserving brain health and wellbeing is an important priority during this time. Older adults (aged ≥65 years, or Indigenous, Pacific patients aged ≥55 years) undergoing major surgery with general anesthesia (excluding heart and brain surgery) and able to provide consent will be able to participate. Participants will be randomized to two groups - a lighter general anesthesia group and a deeper general anesthesia group using processed electroencephalography (a brain monitor that provides information on depth of anesthesia using brain waves). The anesthesiologist will titrate anesthetic drugs according to the brain monitor. Participants will be followed up to determine if they experience delirium after surgery, and longer term impact of delirium such as cognitive and physical decline will also be measured. If found to be effect, this simple, cheap, and widely available treatment could reduce disability, preserve brain health and wellbeing of many older adults undergoing surgery worldwide, and save millions in healthcare dollars.
Eligibility
Inclusion Criteria3
- Patients aged ≥ 65 years, and Māori, Pacific or Indigenous participants aged ≥ 55 years who are undergoing major elective or non-elective surgery with expected surgical duration ≥ 2 hours and postoperative hospital stay ≥ 2 nights.
- Having general anesthesia using total intravenous anesthesia (TIVA) with pEEG monitoring
- Able to provide informed consent (including patients with mild preoperative neurocognitive disorders)
Exclusion Criteria7
- Intracranial or cardiac surgery
- Undergoing surgery with 'wake up' test
- Previous enrollment in Balanced-2 study
- Terminal illness with expected survival <3 months
- Emergency surgery within 6 hours of presentation to hospital
- Cognitive impairment with no capacity to consent or activated enduring power of attorney
- Clinically impaired and unable to consent due to acute pathology or preoperative delirium
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Titration of maintenance anesthetic agent (propofol infusion)
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06268080